Company: PHR
Filing Date: 2025-12-09
Form Type: 10-Q
Source: 0001412408-25-000132
Chunk: 179

Company: Phreesia, Inc.
Filing Date: 2025-12-09
Form: 10-Q
Item: Part I, Item 8
Chunk 179
---
 million in the nine months ended October 31, 2024.

•Net income was $4.3 million in the three months ended October 31, 2025, as compared to net loss of $14.4 million in the three months ended October 31, 2024.

•Net income was $1.0 million in the nine months ended October 31, 2025, as compared to net loss of $52.1 million in the nine months ended October 31, 2024.

•Adjusted EBITDA was $29.1 million in the three months ended October 31, 2025, as compared to $9.8 million in the three months ended October 31, 2024.

•Adjusted EBITDA was $72.1 million in the nine months ended October 31, 2025, as compared to $20.4 million in the nine months ended October 31, 2024.

•Net cash provided by operating activities was $15.5 million for the three months ended October 31, 2025, as compared to $5.8 million for the three months ended October 31, 2024.

•Net cash provided by operating activities was $45.2 million for the nine months ended October 31, 2025, as compared to $16.1 million for the nine months ended October 31, 2024.

•Free cash flow was $8.8 million for the three months ended October 31, 2025, as compared to $1.6 million for the three months ended October 31, 2024.

•Free cash flow was $25.9 million for the nine months ended October 31, 2025, as compared to negative $0.9 million for the nine months ended October 31, 2024.

•Cash and cash equivalents as of October 31, 2025 was $106.4 million, an increase of $22.2 million as compared to January 31, 2025.

For a reconciliation of Adjusted EBITDA to net income (loss) and a reconciliation of free cash flow to net cash provided by operating activities, and for more information as to how we calculate such measures, see the section below titled “Non-GAAP financial measures.”

Overview

37

We are a leading provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations and improve health outcomes by helping patients take a more active role in their care.